Eton Pharmaceuticals IncETON
Price$51.98Intrinsic value$21.6958% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $105.6M+170.7% YoYTTM through 30 Jun 2026
Net Income $12.7MTTM through 30 Jun 2026
Free Cash Flow $14.7MTTM through 30 Jun 2026

Margins

Current
Gross Margin60.7%
EBITDA Margin19.7%
Operating Margin9.9%
Net Margin12.0%

Returns

-4.7%ROE
-1.5%ROA
-2.3%ROIC

Balance Sheet Health

Debt / Equity1.00x
Current Ratio1.21x
Net Debt$11.1M
Cash & Equivalents$26.8M

Quality Metrics

Altman Z-Score14.56
Piotroski F-Score7 / 9
FCF Margin14.0%
Rule of 4055.7
Earnings-Beat Rate25.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $80M
Diluted EPS
'20'21'22'23'24'25
FY2025: $-0.17

Dividend

No dividend

Capital Allocation

R&D Spend$5.8M
Capex Intensity0.4%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.